James T. Borello’s Catalyst Pharmaceutical CPRX Stock Holding History

James T. Borello’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-4	Closed	-$126	–	1289
2026 Q2	$126	Hold	4	–	–	﹤0.01%	1173
2026 Q1	$99	Hold	4	–	–	﹤0.01%	1165
2025 Q4	$93	Buy	+4	New	+$89	﹤0.01%	1089

Other funds holding CPRX

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

James T. Borello's CPRX Position: Q3 2026 in Review

James T. Borello sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 4 shares — an estimated $126 sold.

James T. Borello first reported a position in CPRX in Q4 2025 and held it in 3 quarters. The position peaked at $126 in Q2 2026. 1 fund tracked by Wall St. Rank holds CPRX as of Q3 2026.

James T. Borello reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
James T. Borello sold 4 Catalyst Pharmaceutical shares in Q3 2026, an estimated $126.
James T. Borello first reported a position in Catalyst Pharmaceutical in Q4 2025 and held it in 3 quarters.
James T. Borello's Catalyst Pharmaceutical position peaked at $126 in Q2 2026.
1 fund tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on James T. Borello's 13F filing for Q3 2026, filed 16 Oct 2026.